ArticleFrontiers in endocrinology2022

Novel Pharmacology Following Heteromerization of the Angiotensin II Type 2 Receptor and the Bradykinin Type 2 Receptor.

Elizabeth K M Johnstone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.